Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Get up to date on how experts are integrating CDK4/6 inhibition into adjuvant treatment of early-stage breast cancer with a focused commentary, downloadable patient resource, slides, and an archived webcast from a live workshop.

Share

Program Content

Activities

CDK Inhibition in EBC
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2024

Activities

CDK4.6i in EBC
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 07, 2024

Expires: March 06, 2025

Activities

Adj CDK4/6i Toxicities
How I Manage Key Toxicities With Adjuvant CDK4/6 Inhibitors for Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2023

Activities

HR+/HER2- EBC Patient Resource
HR-Positive/HER2-Negative Early Breast Cancer Patient Resource: Questions for Your Care Team
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Breastcancer.org and Smart Patients Inc.

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner

Smart Patients

ProCE Banner